Based on genomic datasets, the expression profiles of candidate genes in CCA cases were analyzed using GEO databases and the increasing levels of feasible tumor markers including HMGB1, SOX9, and YAP1 in patients with CCA. This evidence concerns the gene SOX9 and cholangiocarcinoma.